Cue Biopharma, Inc. (CUE)
28.45
+2.93
(+11.48%)
USD |
NASDAQ |
Sep 01, 15:48
Cue Biopharma Total Long Term Debt (Quarterly) : 7.179M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.179M |
| March 31, 2026 | 1.878M |
| December 31, 2025 | 2.286M |
| September 30, 2025 | 4.142M |
| June 30, 2025 | 5.52M |
| March 31, 2025 | 3.55M |
| December 31, 2024 | 5.336M |
| September 30, 2024 | 6.617M |
| June 30, 2024 | 8.211M |
| March 31, 2024 | 9.786M |
| December 31, 2023 | 11.33M |
| September 30, 2023 | 12.98M |
| June 30, 2023 | 14.68M |
| March 31, 2023 | 15.37M |
| December 31, 2022 | 16.02M |
| September 30, 2022 | 16.28M |
| June 30, 2022 | 16.67M |
| March 31, 2022 | 14.62M |
| December 31, 2021 | 5.121M |
| Date | Value |
|---|---|
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 1.085M |
| December 31, 2020 | 2.369M |
| September 30, 2020 | 3.633M |
| June 30, 2020 | 4.182M |
| March 31, 2020 | 0.194M |
| December 31, 2019 | 1.348M |
| September 30, 2019 | 2.61M |
| June 30, 2019 | 3.787M |
| March 31, 2019 | 4.947M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| September 30, 2016 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 393.58M |
| Fortress Biotech, Inc. | 46.07M |
| Equillium, Inc. | 0.172M |
| Legend Biotech Corp. | 121.80M |
| Nurix Therapeutics, Inc. | 54.92M |